Acquired factor V inhibitors: a systematic review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Emori Y, Sakugawa M, Niiya K et al (2002) Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagul Fibrinolysis 13:555–559
Wiwanitkit V (2006) Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases. Clin Appl Thromb Hemost 12:485–488
Morris CJ, Curris N (2009) Acquired factor V inhibitor in a critically ill patient. Anaesthesia 64:1014–1017
Franchini M, Gandini G, Di Paolantonio T et al (2005) Acquired hemophilia A: a concise review. Am J Hematol 80:55–63
Franchini M, Targher G, Montagnana M, Lippi G (2008) Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Clin Chim Acta 395:14–18
Ortel T (1999) Clinical and laboratory manifestations of antifactor V antibodies. J Lab Clin Med 133:326–334
Favaloro EJ, Bonar R, Duncan E et al (2006) Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost 96:73–78
Favaloro EJ, Posen J, Ramakrishna R et al (2004) Factor V inhibitors: rare or not so uncommon? A multilaboratory investigation. Blood Coagul Fibrinolysis 15:637–647
Miesbach W, Voigt J, Peetz D, Scharrer I (2003) Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin. Med Klin 98:339–343
Lucia JF, Aguilar C (2005) A case of an asymptomatic idiopathic inhibitor to coagulation factor V. Haemophilia 11:178–180
Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y (2003) Acquired factor V inhibitor complicated by Hashimoto’s thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul Fibrinolysis 14:87–93
Koyama JA, Saito T, Kusano T, Hirosawa S (1995) Factor V inhibitor associated with Sjogren’s syndrome. Br J Haematol 89:893–896
Streiff MB, Ness PM (2002) Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 42:18–26
Banninger H, Hardegger T, Tobler A et al (1993) Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 85:528–532
Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH (2001) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233:88–96
Lu L, Liu Y, Wei J, Zhang L, Yang R (2004) Acquired inhibitor of factor V: first report in China and literature review. Haemophilia 10:661–664
Leus B, Devreese K, Van den Bossche J, Malfait R (2006) Factor V inhibitor: case report. Blood Coagul Fibrinolysis 17:585–587
Kajitani M, Ozdemir A, Aguinaga M, Jazieh AR, Flick JT, Antakli T (2000) Hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product. J Card Surg 15:378–382
Bowman LJ, Anderson CD, Chapman WC (2010) Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost 36:477–484
Ang AL, Kuperan P, Ng CH, Ng HJ (2009) Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost 101:852–859
Ferguson JH, Johnston CL, Howell DA (1958) A circulating inhibitor (anti-AcG) specific for the labile factor-V of the blood-clotting mechanism. Blood 13:382–397
Lopez V, Pflughaupt R, Butler R (1968) A specific inhibitor of human clotting factor V. Acta Haematol 40:275–285
Feinstein DI, Rapaport SI, McGehee WG, Patch MJ (1970) Factor V anticoagulants: clinical, biochemical and immunological observations. J Clin Invest 49:1578–1588
Feinstein DI, Rapaport SI, Chong MMY (1973) Factor V inhibitor: report of a case, with comments on a possible effect of streptomycin. Ann Intern Med 78:385–388
Onuora CA, Lindenbaum J, Nossel HL (1973) Massive hemorrhage associated with circulating antibodies to factor V. Am J Med Sci 265:407–417
Nilsson IM, Hedner U, Ekberg M, Denneberg T (1974) A circulating anticoagulant against factor V. Acta Med Scand 195:73–77
Stenbjerg S, Husted S, Mygind K (1975) A circulating factor V inhibitor: possible side effect of treatment with strepromycin. Scand J Haematol 14:280–285
Coots MC, Muhleman AF, Glueck HI (1978) Hemorrhagic death associated with a high titer factor V inhibitor. Am J Hematol 4:193–206
Lane TA, Shapiro SS, Burka ER (1978) Factor V antibody and disseminated intravascular coagulation. Ann Intern Med 89:182–185
Chediak J, Ashenhurst JB, Garlick I, Desser RK (1980) Sucessful management of bleeding in a patient with factor V inhibitor by platelet transfusion. Blood 56:835–841
Abe T, Kazama M, Itokazu K et al (1980) A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII bypassing activity preparation FEIBA. Rinsho Ketsueki 21:1664–1673
Hida K, Sakamoto S, Takaku F et al (1980) A case of acquired coagulopathy due to factor V inhibitor. Rinsho Ketsueki 21:1589–1596
Lerolle D, Dreyer-Dufer C, Allain JP (1981) A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study. Nouv Presse Med 10:1483–1487
Kuto M, Izuchi Y, Deguchi K, Morito T, Lee C, Wada H (1981) An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer. Nippon Ketsueki Gakkai Zasshi 44:938–950
Vickars LM, Coupland RW, Naiman SC (1985) The response of an acquired factor V inhibitor to activated factor IX concentrate. Transfusion 25:51–53
Chiu HC, Rao AK, beckett C, Colman RW (1985) Immune complexes containing factor V in a patient with an acquired neutralizing antibody. Blood 65:810–818
Nesheim ME, Nichols WL, Cole TL et al (1986) Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 77:405–415
Brandt J, Britton A, Kraut E (1986) A spontaneous factor V inhibitor with unexpected laboratory features. Arch Pathol Lab Med 110:224–227
Lazarchick J, Wolff M, Pepkowitz SH, Kizer J, Romein LA (1986) Factor V inhibitor associated with immune complex formation. Arch Pathol Lab Med 110:448–451
Massignon D, Roullit S, Espinouse D, Coeur P (1989) Occurrence of a circulating anticoagulant, factor V inhibitor after surgical intervention. Ann Fr Anesth Reanim 81:70–72
Okajima A, Horii J, Nasu K et al (1989) Factor V inhibitor with double cancer. Rinsho Ketsueki 30:514–519
Grigg AP, Dauer R, Thurlow PJ (1989) Bleeding due to an acquired inhibitor of platelet associated factor V. Aust NZ J Med 19:310–314
Gordon B, haire W, Duggan M, Langnas A (1991) Factor V inhibitor developing after liver transplantation in a 3-year-old child. Pediatrics 88:156–159
Buclin T, Schmidt PM, Hauert J, Winkel L, Chapuis G, Bachmann F (1992) Acquired factor V inhibitor treated with intravenous immunoglobulins. Schweiz Med Wochenschr 122:1968–1970
Smid WM, de Wolf JTM, Nijland JH, Bom VJJ, van der Meer J (1994) Sever bleeding caused by an inhibitor to coagulation factor V: a case report. Blood Coagul Fibrinolysis 5:133–137
Denis A, Baudeau C, Verdy E, Couderc R, Rondeau E, Sraer JD (1995) Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report. Nouv Rev Fr Hematol 37:165–169
Tribl B, Knobl P, Derfler K et al (1995) Rapid elimination of a high-titer spontanoues factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression. Ann Hematol 71:199–203
George S, Nagabhushana MS, Cyran EM (1995) Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis. Am J Hematol 49:98–100
Suehisa E, Toku M, Akita N et al (1995) Study of an antibody against F1F2 fragment of human factor V in a patient with Hashimoto’s disease and bullous pemphigoid. Thromb Res 77:63–68
Fu YX, Kaufman R, Rudolph AE, Collum SE, Blinder MA (1996) Multimodality therapy of an acquired factor V inhibitor. Am J Hematol 51:315–318
Brickner LA, Scannell KA, Sahud MA (1996) Acquired factor V inibito in a patient with acquired human immunodeficiency syndrome. Am J Hematol 52:332–333
Van Spronsen DJ, Oosting JD, Hoffmann JJML, Breed WPM (1998) Factor V inhibitor associated with cold agglutinin disease. Ann Hematol 76:49–50
Kamphuisen PW, Haan J, Rosekrans PCM, van der Meer FJM (1998) Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features. Am J Hematol 57:176–178
Smith JD, Sindhi R, Rogers R, Lazarchick J (1998) Factor V inhibitor in a liver transplant patient associated with porcine xenoperfusion. Ann Clin Lab Sci 28:280–282
Shastri KA, Ho C, Logue G (1999) An acquired factor V inhibitor: clinical and laboratory features. J Med 30:357–366
Leroy-Matheron C, Mallat A, Duvoux C et al (1999) Inhibitor against coagulation factor V after liver transplantation. Transplantation 68:1054–1056
Jansen M, Schmaldienst S, Banyai S et al (2001) Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol 112:91–97
Bayani N, Rugina M, Haddad-Vergnes L, Lelong F (2002) High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors. Am J Hematol 71:33–36
Takaku T, Kuriyama Y, Shoji N et al (2002) Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis. Rinsho Ketsueki 43:1050–1054
Kalafatis M, Simioni P, Tormene D, Beck DO, Luni S, Girolami A (2002) Isolation and characterization of an antifactor V antibody causino activated protein C resistance from a patient with severe thrombotic manifestations. Blood 99:3985–3992
Hasegawa M, Tanaka T, Kii T et al (2003) Acquired inhibitor against coagulation factor V with severe hematuria. Rinsho Ketsueki 44:933–939
Okoshi Y, Akiyama H, Inoue T et al (2003) A long-lasting idiopathic factor V inhibitor. Rinsho Ketsueki 44:14–18
Ajzner E, Balogh I, Haramura G et al (2003) Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. J Thromb Haemost 1:943–999
de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C (2003) High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. Am J Hematol 74:187–190
Lian EC, Tzakis AG, Andrews D (2004) Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. Am J Hematol 77:363–365
Tukić L, Stamatović D, Tarabar O, Elez M, Zorić M, Mandić-Radić S (2005) Acquired factor V inhibitors in a polytraumatized patient. Vojnosanit Pregl 62:587–590
Godart B, Boinot C, Remblier C, Hajjar A, Beauchant M (2006) Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient. Gut 55:134–135
Perdekamp MT, Rubenstein DA, Jesty J, Hultin MB (2006) Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assys. Blood Coagul Fibrinolysis 17:593–597
Gacina P, Kusec R, Carzavec D, Raic B, Stancic V (2006) Acquired factor V inhibitor: a case report. Acta Clin Croat 45:199–201
Endo H, Kawauchi K, Tomimatsu M et al. (2007) Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers. Intern Med 46:621–625
Maughan EO, Wilson J, Wilde JT (2007) Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma. Int J Lab Hematol 29:316–319
Milojkovic D, Patel R, Ford E, Arya R, Mufti G (2007) Acquired factor V inhibitor after hematopoietic stem cell transplantation. Thromb Haemost 98:685–687
Shimizu I, Ichikawa N, Yotsumoto M, Sumi M, Ueno M, Kobayashi H (2008) High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors. Rinsho Ketsueki 49:413–416
Jeimy SB, Krakow EF, Fuller N, Tasneem S, Hayward CPM (2008) An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1. J Thromb Haemost 6:395–397
Lebrun A, Leroy-Matheron C, Arlet JB, Bartolucci P, Michel M (2008) Successful treatment with rituximab in a patient with an acquired factor V inhibitor. Am J Hematol 83:163–164
William BM (2008) Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor. Blood Coagul Fibrinolysis 19:327–328
Gadelha T, Aquino JHW, Silva EA, Santos FL, de Oliveira MHFC (2008) The diversity in clinical presentation of acquired factor V inhibitor, two case reports. Acta Haematol 119:108–110
Kindler S, Siegemund T, Fuhrer D, Petros S (2008) Thrombin generation assay in a patient with acquired factor V inhibitor. J Thromb Haemost 6:1985–1987
Shanmugam H, Jayaranee S, Eow GI (2010) A case report of an acquired inhibitor to coagulation factor V. Haemophilia [Epub ahead of print]
Tessier-Marteau A, Croquefer S, Meziani F, Cau S, Asfar P, Macchi L (2010) Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation. Am J Hematol 85:145–146
Franchini M, Lippi G (2010) Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Haemost 36:485–492